Journal
CANCER LETTERS
Volume 420, Issue -, Pages 14-25Publisher
ELSEVIER IRELAND LTD
DOI: 10.1016/j.canlet.2018.01.062
Keywords
Gastric cancer; Hippo pathway; YAP
Categories
Funding
- China Postdoctoral Science Foundation [2017M621955]
- National Natural Science Foundation of China [81571799, 81773193, 81421062, 91542205]
Ask authors/readers for more resources
The Hippo tumor suppressor pathway is critical for balancing cellular differentiation and proliferation in response to cell-cell contact, mechanical signals and diffusible signals such as lysophosphatidic acid. Hippo pathway signaling is frequently dysregulated in gastric cancer (GC), as well as many other kinds of solid tumors, contributing to multiple aspects of malignant progression including unchecked cell division and metastasis. Considering the importance of this Hippo pathway in cancer, its pharmacological disruption may be of huge benefit in the fight against this disease. In this review, we summarize the components of the Hippo pathway, its crosstalk with other major oncogenic signaling pathways, common mechanisms of its dysregulation, as well as potential therapeutic approaches of targeting this pathway for cancer treatment, specifically in a GC context. (C) 2018 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available